Please try another search
Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities. Its subsidiary, NuGenerex Immuno-Oncology, Inc., is focused on the modulation of the immune system and activation of T cells to treat cancer. Its lead cancer immunotherapy product candidate is AE37, an Ii-Key-HER2 peptide vaccine for breast, prostate, and bladder cancer, which links its li-Key to a designated tumor antigen like HER-2 to activates the immune system to target specific cancer cells. NuGenerex Health LLC provides ancillary health services in the areas of eyecare, podiatry and chronic care management. NuGenerex Regenerative Medicine is focused on developing drugs, medical devices and therapeutics to improve treatment outcomes. Nugenerex Diagnostics, Inc. manufactures in-vitro medical diagnostic devices for both point of care and laboratory-based tests, primarily for infectious diseases.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review